Literature DB >> 21077738

Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia.

Pier Paolo Piccaluga, Mario Arpinati, Anna Candoni, Claudio Laterza, Stefania Paolini, Anna Gazzola, Elena Sabattini, Giuseppe Visani, Stefano A Pileri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21077738     DOI： 10.3109/10428194.2010.529206

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  36 in total

1.  Characterization of CD22 expression in acute lymphoblastic leukemia.

Authors:  Nirali N Shah; Maryalice Stetler Stevenson; Constance M Yuan; Kelly Richards; Cindy Delbrook; Robert J Kreitman; Ira Pastan; Alan S Wayne
Journal:  Pediatr Blood Cancer       Date:  2015-03-01       Impact factor: 3.167

Review 2.  Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.

Authors:  Hagop Kantarjian; Deborah Thomas; Alan S Wayne; Susan O'Brien
Journal:  J Clin Oncol       Date:  2012-08-13       Impact factor: 44.544

Review 3.  No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Authors:  Tania Jain; Mark R Litzow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 4.  No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Authors:  Tania Jain; Mark R Litzow
Journal:  Blood Adv       Date:  2018-11-27

Review 5.  Mechanisms of resistance to CAR T cell therapy.

Authors:  Nirali N Shah; Terry J Fry
Journal:  Nat Rev Clin Oncol       Date:  2019-06       Impact factor: 66.675

Review 6.  Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure rates.

Authors:  Michael S Mathisen; Hagop Kantarjian; Deborah Thomas; Susan O'Brien; Elias Jabbour
Journal:  Leuk Lymphoma       Date:  2013-06-21

Review 7.  Monoclonal antibodies in acute lymphoblastic leukemia.

Authors:  Elias Jabbour; Susan O'Brien; Farhad Ravandi; Hagop Kantarjian
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

8.  Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody.

Authors:  Elias Jabbour; Susan O'Brien; Xuelin Huang; Deborah Thomas; Michael Rytting; Koji Sasaki; Jorge Cortes; Guillermo Garcia-Manero; Tapan Kadia; Farhad Ravandi; Sherry Pierce; Hagop Kantarjian
Journal:  Am J Hematol       Date:  2015-01-16       Impact factor: 10.047

9.  CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells.

Authors:  Wenjie Peng; James C Paulson
Journal:  J Am Chem Soc       Date:  2017-08-31       Impact factor: 15.419

Review 10.  Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodies.

Authors:  Naval Daver; Susan O'Brien
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.